Insights into the transition of ductal carcinoma in situ to invasive ductal carcinoma: morphology, molecular portraits, and the tumor microenvironment

被引:5
作者
Chen, Weiling [1 ,2 ,3 ,4 ,5 ]
Wang, Guimei [5 ,6 ]
Zhang, Guojun [1 ,2 ,3 ,4 ,5 ]
机构
[1] Xiamen Univ, XiangAn Hosp, Sch Med, Dept Breast Thyroid Surg, Xiamen 361101, Peoples R China
[2] Xiamen Univ, XiangAn Hosp, Sch Med, Canc Ctr, Xiamen 361101, Peoples R China
[3] Xiamen Univ, XiangAn Hosp, Fujian Key Lab Precis Diag & Treatment Breast Can, Xiamen 361101, Peoples R China
[4] Xiamen Univ, XiangAn Hosp, Key Lab Endocrine Related Canc Precis Med Xiamen, Xiamen 361101, Peoples R China
[5] Xiamen Univ, XiangAn Hosp, Xiamen Res Ctr Clin Med Breast & Thyroid Canc, Xiamen 361101, Peoples R China
[6] Xiamen Univ, XiangAn Hosp, Dept Pathol, Xiamen 361101, Peoples R China
关键词
BREAST-CANCER; PROGRESSION; EXPRESSION; STAGE;
D O I
10.20892/j.issn.2095-3941.2022.0440
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1487 / 1495
页数:9
相关论文
共 50 条
  • [31] Are the Pure In Situ Breast Ductal Carcinomas and Those Associated With Invasive Carcinoma the Same?
    Schorr, Mario Casales
    Pedrini, Jose Luiz
    Savaris, Ricardo Francalacci
    Zettler, Claudio Galleano
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2010, 18 (01): : 51 - 54
  • [32] Modeling Human Ductal Carcinoma In Situ in the Mouse
    Behbod, Fariba
    Gomes, Angelica M.
    Machado, Heather L.
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2018, 23 (04) : 269 - 278
  • [33] Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer
    Muggerud, Aslaug Aamodt
    Hallett, Michael
    Johnsen, Hilde
    Kleivi, Kristine
    Zhou, Wenjing
    Tahmasebpoor, Simin
    Amini, Rose-Marie
    Botling, Johan
    Borresen-Dale, Anne-Lise
    Sorlie, Therese
    Warnberg, Fredrik
    MOLECULAR ONCOLOGY, 2010, 4 (04): : 357 - 368
  • [34] Grade of Ductal Carcinoma In Situ Accompanying Infiltrating Ductal Carcinoma As an Independent Prognostic Factor
    Kim, Ju-Yeon
    Han, Wonshik
    Moon, Hyeong-Gon
    Park, In-Ae
    Ahn, Soo Kyung
    Kim, Jisun
    Lee, Jun Woo
    Kim, Taeryung
    Kim, Min Kyoon
    Noh, Dong-Young
    CLINICAL BREAST CANCER, 2013, 13 (05) : 385 - 391
  • [35] The prognostic significance of immune microenvironment in breast ductal carcinoma in situ
    Toss, Michael S.
    Abidi, Asima
    Lesche, Dorothea
    Joseph, Chitra
    Mahale, Sakshi
    Saunders, Hugo
    Kader, Tanjina
    Miligy, Islam M.
    Green, Andrew R.
    Gorringe, Kylie L.
    Rakha, Emad A.
    BRITISH JOURNAL OF CANCER, 2020, 122 (10) : 1496 - 1506
  • [36] Asynchronous LOH analysis of ductal carcinoma in situ from patients who subsequently developed invasive ductal carcinoma
    M Amari
    T Moriya
    Y Harada
    T Ishida
    K Ohnuki
    N Ohuchi
    Breast Cancer Research, 3 (Suppl 1)
  • [37] Ductal carcinoma in situ and invasive carcinoma originating in a Fibroadenoma with concurrent benign phyllodes tumor: A case report
    Ahmad, Afaq
    Najeeb, Erum
    Ul Haq, Muhammad Burhan
    Bashir, Humaira
    Uzair, Muhammad
    Mamoon, Nadira
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2024, 116
  • [38] The role of stromal immune microenvironment in the progression of ductal carcinoma in situ (DCIS) to invasive breast cancer
    Anna Niwińska
    Wojciech P. Olszewski
    Breast Cancer Research, 23
  • [39] Progression from ductal carcinoma in situ to invasive breast cancer: Revisited
    Cowell, Catherine F.
    Weigelt, Britta
    Sakr, Rita A.
    Ng, Charlotte K. Y.
    Hicks, James
    King, Tari A.
    Reis-Filho, Jorge S.
    MOLECULAR ONCOLOGY, 2013, 7 (05) : 859 - 869
  • [40] The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin
    Schnitt, Stuart J.
    BREAST CANCER RESEARCH, 2009, 11 (01)